Search

Your search keyword '"Abbasi, Jennifer"' showing total 27 results
Start Over Author "Abbasi, Jennifer" Topic sars-cov-2
27 results on '"Abbasi, Jennifer"'

16. "Nanotraps" Designed to Capture and Clear SARS-CoV-2.

Author

Abbasi J

Subjects
Antibodies, Neutralizing therapeutic use, Humans, Nanotechnology methods, Angiotensin-Converting Enzyme 2 physiology, Antibodies, Neutralizing physiology, COVID-19 therapy, Nanoparticles therapeutic use, SARS-CoV-2 drug effects, SARS-CoV-2 immunology
Published
2021
Full Text
View/download PDF

17. Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants.

Author

Abbasi J

Subjects
Antibodies, Monoclonal, Humanized therapeutic use, COVID-19 therapy, COVID-19 transmission, COVID-19 virology, Chronic Disease, Hematologic Neoplasms complications, Hematologic Neoplasms immunology, Humans, Immune System Diseases complications, Immune System Diseases immunology, Immunization, Passive, Immunosuppression Therapy adverse effects, Patient Isolation, Time Factors, COVID-19 Serotherapy, COVID-19 immunology, Immunocompromised Host, SARS-CoV-2 genetics
Published
2021
Full Text
View/download PDF

23. CRISPR-Based COVID-19 Smartphone Test in Development.

Author

Abbasi J

Subjects
Humans, Microscopy, Fluorescence, Nose virology, RNA, Viral isolation & purification, SARS-CoV-2 isolation & purification, Viral Load, COVID-19 diagnosis, COVID-19 Nucleic Acid Testing methods, CRISPR-Cas Systems, SARS-CoV-2 genetics, Smartphone
Published
2021
Full Text
View/download PDF

25. JAMA Network Articles of the Year 2020.

Author

Abbasi, Jennifer

Subjects
*PUBLISHED articles, *COVID-19, *CHLOROQUINE, *SARS-CoV-2, *PEDIATRICS, *MEDICAL masks
Abstract

This Medical News article discusses the top-viewed research articles published across the JAMA Network in the past year. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

26. COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity.

Author

Abbasi, Jennifer

Subjects
*SARS-CoV-2, *VACCINATION, *BREAKTHROUGH infections
Abstract

The article reports on the tendency of people infected with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) after being vaccinated against the virus to have milder and shorter illnesses based on data from studies funded by the U.S. Centers for Disease Control and Prevention in 2021.

Published
2021
Full Text
View/download PDF

27. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.

Author

Abbasi, Jennifer

Subjects
*ANTIVIRAL agents, *SARS-CoV-2, *COVID-19, *VIRAL pneumonia, *HIGH throughput screening (Drug development), *EPIDEMICS, *MEDICAL prescriptions, *PHARMACODYNAMICS
Abstract

The article reports on a study conducted by scientists at the Sanford Burnham Prebys Medical Discovery Institute that winnowed down about 12,000 approved and investigational drugs to 13 promising candidates against severe acute respiratory syndrome coronavirus 2 that causes COVID-19.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results